Axsome Therapeutics, Inc. (AXSM) — insider trading
Health Care · Nasdaq
Axsome Therapeutics, Inc. (AXSM) has 26 reported SEC Form 4 insider transactions in our data, including 8 open-market sales among the most recent 26 (latest 2026-07-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | TABUTEAU HERRIOT | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion (derivative) | 49,666 | $0.00 | $0 | Form 4 |
| 2026-07-01 | TABUTEAU HERRIOT | Director, Officer (Chief Executive Officer), 10% owner | Open-market sale | 49,666 | $240.25 | $11.93M | Form 4 |
| 2026-07-01 | TABUTEAU HERRIOT | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion | 49,666 | $4.95 | $245.8K | Form 4 |
| 2026-06-11 | JEFFS ROGER | Director | Open-market sale | 286 | $249.12 | $71.2K | Form 4 |
| 2026-06-10 | JEFFS ROGER | Director | Open-market sale | 286 | $246.18 | $70.4K | Form 4 |
| 2026-06-10 | Coleman Mark | Director | Open-market sale | 643 | $249.00 | $160.1K | Form 4 |
| 2026-06-10 | Mahony Susan | Director | Open-market sale | 300 | $246.18 | $73.9K | Form 4 |
| 2026-06-09 | Mahony Susan | Director | Open-market sale | 300 | $237.21 | $71.2K | Form 4 |
| 2026-06-09 | Pizzie Nick | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 33,000 | $0.00 | $0 | Form 4 |
| 2026-06-09 | Pizzie Nick | Officer (Chief Financial Officer) | Open-market sale | 33,000 | $240.09 | $7.92M | Form 4 |
| 2026-06-09 | Pizzie Nick | Officer (Chief Financial Officer) | Option exercise / conversion | 33,000 | $3.50 | $115.5K | Form 4 |
| 2026-06-09 | TABUTEAU HERRIOT | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion (derivative) | 49,670 | $0.00 | $0 | Form 4 |
| 2026-06-09 | TABUTEAU HERRIOT | Director, Officer (Chief Executive Officer), 10% owner | Open-market sale | 49,670 | $241.01 | $11.97M | Form 4 |
| 2026-06-09 | TABUTEAU HERRIOT | Director, Officer (Chief Executive Officer), 10% owner | Option exercise / conversion | 49,670 | $4.95 | $245.9K | Form 4 |
| 2026-06-08 | Coleman Mark | Director | Option exercise / conversion (derivative) | 1,429 | $0.00 | $0 | Form 4 |
| 2026-06-08 | Coleman Mark | Director | Option exercise / conversion | 1,429 | — | — | Form 4 |
| 2026-06-08 | Mahony Susan | Director | Option exercise / conversion (derivative) | 1,429 | $0.00 | $0 | Form 4 |
| 2026-06-08 | Mahony Susan | Director | Option exercise / conversion | 1,429 | — | — | Form 4 |
| 2026-06-08 | Saad Mark E | Director | Option exercise / conversion (derivative) | 1,429 | $0.00 | $0 | Form 4 |
| 2026-06-08 | Saad Mark E | Director | Option exercise / conversion | 1,429 | — | — | Form 4 |
| 2026-06-08 | JEFFS ROGER | Director | Option exercise / conversion (derivative) | 1,429 | $0.00 | $0 | Form 4 |
| 2026-06-08 | JEFFS ROGER | Director | Option exercise / conversion | 1,429 | — | — | Form 4 |
| 2026-06-05 | JEFFS ROGER | Director | Grant / award / vesting (derivative) | 1,721 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Saad Mark E | Director | Grant / award / vesting (derivative) | 1,721 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Mahony Susan | Director | Grant / award / vesting (derivative) | 1,721 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Coleman Mark | Director | Grant / award / vesting (derivative) | 1,721 | $0.00 | $0 | Form 4 |
Ask the chat about AXSM's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Axsome Therapeutics, Inc. (AXSM).
Last updated 2026-07-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.